Lifevantage (NASDAQ:LFVN) Shares Pass Below 200-Day Moving Average – What’s Next?

Lifevantage Corporation (NASDAQ:LFVN)’s share price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $7.57 and traded as low as $4.71. Lifevantage shares last traded at $5.09, with a volume of 88,043 shares.

Analyst Ratings Changes

A number of research firms have weighed in on LFVN. Loop Capital set a $5.00 price target on shares of Lifevantage in a research report on Thursday, February 5th. Lake Street Capital restated a “buy” rating on shares of Lifevantage in a research report on Thursday, February 5th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Lifevantage in a research note on Monday, December 29th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $5.00.

Lifevantage Stock Performance

The company has a market capitalization of $65.10 million, a PE ratio of 8.48 and a beta of 0.36. The stock has a fifty day moving average of $5.48 and a 200 day moving average of $7.57.

Lifevantage (NASDAQ:LFVN) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.07). The company had revenue of $48.93 million for the quarter, compared to analysts’ expectations of $54.40 million. Lifevantage had a net margin of 3.74% and a return on equity of 29.59%. Lifevantage has set its FY 2026 guidance at 0.600-0.800 EPS.

Lifevantage Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be paid a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a yield of 3.5%. The ex-dividend date of this dividend is Monday, March 2nd. Lifevantage’s dividend payout ratio (DPR) is presently 30.00%.

Insider Transactions at Lifevantage

In related news, Director Judd Dayton purchased 10,500 shares of the firm’s stock in a transaction on Monday, March 2nd. The shares were acquired at an average price of $4.53 per share, for a total transaction of $47,565.00. Following the purchase, the director directly owned 80,359 shares in the company, valued at $364,026.27. This trade represents a 15.03% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In the last 90 days, insiders have acquired 37,957 shares of company stock valued at $178,332. Insiders own 21.95% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Aristides Capital LLC bought a new stake in shares of Lifevantage in the fourth quarter worth about $76,000. Virtu Financial LLC bought a new position in Lifevantage during the fourth quarter valued at approximately $146,000. Invesco Ltd. grew its holdings in Lifevantage by 13.6% during the 4th quarter. Invesco Ltd. now owns 30,085 shares of the company’s stock valued at $185,000 after buying an additional 3,603 shares in the last quarter. XTX Topco Ltd bought a new stake in Lifevantage in the 4th quarter worth approximately $206,000. Finally, AQR Capital Management LLC increased its stake in Lifevantage by 141.5% in the 4th quarter. AQR Capital Management LLC now owns 56,289 shares of the company’s stock worth $347,000 after acquiring an additional 32,985 shares during the last quarter. Hedge funds and other institutional investors own 35.32% of the company’s stock.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.